Industry Outlook
The in-vitro fertilization market is set to reach from US$ 15,604.7 Mn in 2017 to US$ 36,854.0 Mn in 2026 projecting outstanding growth at a compounded annual growth rate of 10.1% during the forecast period from 2018 to 2026. Significant rise in couples to have children at later stage of life owing to increasing preference for professional career and technological adoption in IVF treatment will drive the market growth in the forthcoming years.
Market Synopsis
Get a sample copy for more information
"Increased research activites to improve culture media and capability in sperm preservation without losing on quality drive the market growth for culture media"
Culture media are currently holding the largest market share by instruments in the in-vitro fertilization market. Chief attributing factors are increased research activites in improving culture media and capability in preserving sperm without losing on quality. Increasing demand for egg processing media and establishment of numerous egg cryobanks further bolster the market growth for culture media. Strict regulatory mandates and need for maintaining optimum sterile conditions will propel the market growth of disposable devices at a faster rate.
Get a sample copy for more information
"Frozen non-donor will be the fastest growing segment due to excellent live birth rate, better implementation and lower miscarriage rate"
Fresh non-donor is currently reigning the type segment for in-vitro fertilization market. High success rate in the first attempt is the major factor responsible for its impressive market growth. Frozen non-donor will be showcasing outstanding growth in the next few years on account of excellent live birth rate, better implementation, reduced cases of ectopic pregnancy and lower miscarriage rate.
Get a sample copy for more information
"Availability of sophisticated equipment and significant rise in couples opting Assistive Reproductive Technology (ART) drive the market growth for fertility clinics"
Fertility clinics are dominating the end user segment for in-vitro fertilization market. Significant rise in the couples opting for ART treatment, Intracytoplasmic Sperm Injection (ICST) and Gamete Intrafallopian Transfer (GIFT) drive the fertility clinics market growth. Hospitals are showcasing steady growth on account of enhanced government funding to provide IVF treatment to poor families and rising public health awareness pertaining to infertility treatment.
"Rising prevalence of infertility and adoption of sophisticated technology pertaining to IVF drives the market growth in North America region"
North America is accountable for 35% market growth and is the leading regional segment for in-vitro fertilization market. The assisting factors responsible for its market dominance are rising prevalence of infertility. As per the research findings of American Society for Reproductive Medicine (ASRM), approximately 6.7 million women are suffering with infertility in the United States, which represents 11.0% of the reproductive population. Europe holds 30% market share owing to the government initiatives of providing monetary benefits pertaining to gametes freezing and IVF cycles. Asia Pacific represents 20% market share and will capture the market in the next few years on account of presence of large target population, adoption of sophisticated technology and low treatment cost in comparison to developed countries.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
In-vitro fertilization market segmentation is as follows:
| ATTRIBUTE |
DETAILS |
| Research Period |
2017-2027 |
| Base Year |
2018 |
| Forecast Period |
2019-2027 |
| Historical Year |
2017 |
| Unit |
USD Million |
| Segmentation |
By Instrument (2016–2026; US$ Mn)
• Disposable Devices
• Culture Media
• Capital Equipment
|
|
By Type (2016–2026; US$ Mn)
• Fresh Donor
• Frozen Donor
• Fresh Non-Donor
• Frozen Non-Donor
|
|
By End User (2016–2026; US$ Mn)
• Fertility Clinics
• Hospitals
|
|
Geography Segment (2016–2026; US$ Mn)
• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
Biopharmaceuticals specializing in in-vitro fertilization market are Boston IVF, Cook Medical, Inc., Cooper Surgical, Inc., EMD Serono, Inc., Genea Biomedx, Irvine Scientific, Inc., OvaScience, Inc., Progyny, Inc., Thermo Fisher Scientific, Inc. and Vitrolife AB.
Key questions answered in this report
- Which major players are providing culture media and disposable devices related to in-vitro fertilization treatment?
- What are the latest treatment protocols adopted in in-vitro fertilization?
- Which factors are responsible for rising prevalence of infertility throughout the world?
- What will be the market size for disposable devices in the near future?
- Why is fresh non-donor the leading type segment in in-vitro fertilization market?
- What will be the market performance of fertility clinics and hospitals during the forecast period?
- What is the treatment regimen adopted in developed regions such as Europe and North America?
